Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • What Makes Ampion Different?
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • What Makes Ampion Different?
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2021

Audio Recording of the Q1 2021 Earnings Call on May 5, 2021

Ampio Pharmaceuticals’ Presentation at the Benzinga Biotech Small Cap Conference held virtually on March 24 & 25, 2021

David Bar-Or

How Ampion Can be Used to Treat COVID-19

An interview with Dr. David Bar-Or, MD   December 16, 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 12, 2020

Audio Recording of the Q3 2020 Earnings Call on November 5, 2020

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.
Loading

Latest News

Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress

May 21, 2021

Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)

May 10, 2021

Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

May 5, 2021
member-logo-85

Twitter icon

© 2021 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Manufacturing
  • Investors
  • News
  • Contact Us